Announcing a new publication for Acta Materia Medica journal. Bioresponsive materials have gained prominence as innovative ...

HBO is a network built on quality content. The following series are no exception to that rule, but each deserves a larger audience.

Fully cell-free process aims to democratize personalized cancer therapeutics with shorter turnaround and negligible bioburden ...

Cybin has made steady progress but faces major hurdles, with its stock swayed by sector sentiment. Read why CYBN stock is ...

Gene therapeutic strategies for peripheral artery disease. Neovascularization in ischemic limbs may be achieved by transducing vascular endothelium directly with viral-delivered transgenes or ncRNA ...

In parallel, e-therapeutics has successfully completed GMP manufacturing of the clinical batch of ETX-312, supporting the Company’s operational readiness to progress to first-in-human dosing.

Understanding the duration of partial hospitalization programs (PHP) is crucial for patients and providers alike. The length ...

Recent developments in protein-protein interactions (PPI) give hope for patients with advanced or untreatable diseases.

Thus, blocking the interaction between MID1 and mutant HTT mRNA is a promising therapeutic approach. Additionally, we show that MID1 expression in the brain of both HD patients and HD mice is ...

TEL AVIV, Israel (AP) — U.S. President Donald Trump on Sunday urged progress in ceasefire talks in the 20-month war in Gaza between Israel and Hamas, though some weary Palestinians were skeptical ...

President Biden’s 100-day progress report Here’s how President Joe Biden is doing with the initiatives he promised for his first 100 days in office.

President Trump pleaded for progress in ceasefire talks in the war in Gaza, as Israel and Hamas appeared to be inching closer to an agreement.